Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and version bump to v3.2.0; removed the previous v3.1.0 version reference.
    Difference
    2%
    Check dated 2025-10-05T10:04:59.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    - Updated software version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:14:00.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.1 to v3.0.2. Removed the 'Back to Top' element as a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-13T17:40:31.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T15:23:54.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new scientific terms related to pharmacology and disease. Notably, previous content regarding specific antineoplastic agents and related topics has been removed.
    Difference
    2%
    Check dated 2025-08-30T12:13:35.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:42:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.